Elevance Health Inc (NYSE: ELV) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.81 versus $3.65 for the same period a year ago — a decline of -50%. For the latest four quarters through December 31, E.P.S. were $25.68 versus $25.38 for the same period a year ago — an increase of 1%.
Recent Price Action
Elevance Health Inc (NYSE: ELV) stock closed at $401.36 on 1/23/25 after a large increase of 2.7%. Moreover, this advance was accompanied by unusually high trading volume at 167% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 2.1% during the last week.
Current PriceTarget Research Rating
Elevance Health has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Elevance Health has a slightly positive Appreciation Score of 64 but a poor Power Rating of 29, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment